Lysate from MTP-treated tumors showed an even stronger upregulation of chemokines involved in immune cell recruitment, including CXCL9, CCL5, CXCL10, CD40 and CXCL16, compared to both control and MTX-treated tumor lysates (Fig. 6G). The gene discussed is CCL5; the disease is neoplasm.